Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 5,530 | 7,977 | 1,289 | 2,175 | N/A |
| Receivables | 156 | N/A | 150 | 151 | N/A |
| Inventories | 551 | 109 | N/A | N/A | N/A |
| TOTAL | $6,404 | $8,338 | $1,524 | $2,388 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 86 | 58 | 63 | 106 | N/A |
| Intangibles | 1,635 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 76 | 0 | 0 | 21 | 0 |
| TOTAL | $1,797 | $58 | $63 | $127 | $N/A |
| Total Assets | $8,201 | $8,396 | $1,587 | $2,514 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 695 | 987 | 58 | 220 | 0 |
| Accrued Expenses | 1,633 | 202 | 129 | 191 | N/A |
| Other current liabilities | 865 | 0 | N/A | N/A | N/A |
| TOTAL | $3,193 | $1,290 | $14,178 | $11,542 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 1,785 | 18,296 | 1,465 | 1,360 | 0 |
| TOTAL | $1,785 | $18,296 | $1,465 | $1,360 | $N/A |
| Total Liabilities | $4,977 | $19,586 | $15,643 | $12,902 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 205 | 90 | N/A | N/A | N/A |
| Common Shares | 14 | 7 | 1 | 1 | N/A |
| Retained earnings | -86,247 | -70,338 | -57,101 | -53,393 | N/A |
| TOTAL | $3,224 | $-11,190 | $-14,056 | $-10,388 | $N/A |
| Total Liabilities And Equity | $8,201 | $8,396 | $1,587 | $2,514 | $0 |